Back to Results

Park Ha Biological Technology Co (BYAH)

Park Ha Biological Technology Co. is a common equity listing on NASDAQ for Park Ha Biological Technology Co., Ltd., a company based in Wuxi, China. The company operates as an investment holding company focused on skincare products in the People’s Republic of China. Its business is organized into two segments: Product Sales and Franchise Service. Through the Park Ha brand, it develops and sells items including products aimed at skin protection, exfoliation, sebum film repair, and anti-aging. Sales are made through directly operated retail stores and franchisees. Founded in 2016, the company is a subsidiary of Xiaoqiu Holding Ltd.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-BYAH
$0.70
67.0% Upside
Bargain
—
—
—
Weak
—
—
—
0.0%
—
-0.1x
0.7x
1.2x
2.939 M
-668.669 K
5.7%
62.8%
-31.0
—
0.0%
Send a message
Valuation • Fair Value

Park Ha Biological Technology Co (NASDAQ-BYAH) Fair Value by Valuation Model

Compare the primary fair value estimate for Park Ha Biological Technology Co (NASDAQ-BYAH) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$0.70

Estimated upside of 67.0% versus the current market price.

Fair Value Confidence

Very low

Confidence level for the primary fair value estimate.

DCF Fair Value

$0.84

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$0.63

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for Park Ha Biological Technology Co (NASDAQ-BYAH) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Park Ha Biological Technology Co (NASDAQ-BYAH)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

2.525 M

Current operating scale indicator.

Revenue Forecast

2.613 M

Forward revenue estimate.

EBITDA

-24.04 M

Current operating profitability reference.

EBITDA Forecast

Not available

Data is currently unavailable.

How to read profitability and growth

This section helps investors review Park Ha Biological Technology Co (NASDAQ-BYAH) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Park Ha Biological Technology Co (NASDAQ-BYAH)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

3

Weak quality score that deserves closer review.

Beneish M-Score

-24.82

No elevated caution signal from this screen.

Altman Z-Score

-31.0

Lower score that deserves closer risk review.

FCF / Net Income

0.0%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Park Ha Biological Technology Co (NASDAQ-BYAH). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Park Ha Biological Technology Co (NASDAQ-BYAH)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

Not available

Days to Earnings

Not available

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Park Ha Biological Technology Co (NASDAQ-BYAH), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Park Ha Biological Technology Co (NASDAQ-BYAH) Stock Forecast & Technical Outlook

Review Park Ha Biological Technology Co (NASDAQ-BYAH) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Park Ha Biological Technology Co (NASDAQ-BYAH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Park Ha Biological Technology Co (NASDAQ-BYAH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Park Ha Biological Technology Co (NASDAQ-BYAH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Park Ha Biological Technology Co (NASDAQ-BYAH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Park Ha Biological Technology Co (NASDAQ-BYAH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Park Ha Biological Technology Co (NASDAQ-BYAH)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for Park Ha Biological Technology Co (NASDAQ-BYAH) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ • Fast Investor Answers

Park Ha Biological Technology Co (NASDAQ-BYAH) Stock FAQ

Quick answers about Park Ha Biological Technology Co (NASDAQ-BYAH) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$0.70
Estimated upside 67.0%
Valuation Rating
Undervalued
Estimated upside of 67.0%
Analyst Target
Not available
Data is currently unavailable
Financial Health
Weak
Current financial-health read

The current fair value estimate for Park Ha Biological Technology Co (NASDAQ-BYAH) is $0.70. This implies an estimated upside of 67.0% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 67.0% versus the current market price.

An analyst price target for Park Ha Biological Technology Co (NASDAQ-BYAH) is not currently available in the latest data file.

The current financial health read for Park Ha Biological Technology Co (NASDAQ-BYAH) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Park Ha Biological Technology Co (NASDAQ-BYAH) is -0.1x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Park Ha Biological Technology Co is 2.939 M.

The current enterprise value listed for Park Ha Biological Technology Co is -668.669 K. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Park Ha Biological Technology Co is NASDAQ-BYAH, and the stock is listed on NASDAQ.

Park Ha Biological Technology Co (NASDAQ-BYAH) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Park Ha Biological Technology Co is 5.7%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Park Ha Biological Technology Co is 62.8%. Free float helps investors understand how much of the share base is available for public trading.

Similar Specialty Retail Stocks on NASDAQ View more

Ross Stores Inc (ROST) Ross Stores Inc (ROST)
O’Reilly Automotive Inc (ORLY) O’Reilly Automotive Inc (ORLY)
Ulta Beauty Inc (ULTA) Ulta Beauty Inc (ULTA)
Tractor Supply Company (TSCO) Tractor Supply Company (TSCO)
Five Below Inc (FIVE) Five Below Inc (FIVE)
Urban Outfitters Inc (URBN) Urban Outfitters Inc (URBN)
Academy Sports Outdoors Inc (ASO) Academy Sports Outdoors Inc (ASO)
National Vision Holdings Inc (EYE) National Vision Holdings Inc (EYE)
TheRealReal Inc (REAL) TheRealReal Inc (REAL)
Winmark Corporation (WINA) Winmark Corporation (WINA)
Upbound Group Inc (UPBD) Upbound Group Inc (UPBD)
Arhaus Inc (ARHS) Arhaus Inc (ARHS)
Arko Petroleum Inc (APC) Arko Petroleum Inc (APC)
Arko Corp (ARKO) Arko Corp (ARKO)
ThredUp Inc (TDUP) ThredUp Inc (TDUP)
Petco Health and Wellness Company Inc (WOOF) Petco Health and Wellness Company Inc (WOOF)
Citi Trends Inc (CTRN) Citi Trends Inc (CTRN)
Monro Muffler Brake Inc (MNRO) Monro Muffler Brake Inc (MNRO)
Evgo Inc (EVGO) Evgo Inc (EVGO)
Stitch Fix (SFIX) Stitch Fix (SFIX)
Lands’ End Inc (LE) Lands’ End Inc (LE)
Uxin Ltd (UXIN) Uxin Ltd (UXIN)
Zumiez Inc (ZUMZ) Zumiez Inc (ZUMZ)
1-800 FLOWERS.COM Inc (FLWS) 1-800 FLOWERS.COM Inc (FLWS)